Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors

Published:2017-08 Issue: Volume:136 Page:315-329
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Abdullaziz Mona A.,Abdel-Mohsen Heba T.,El Kerdawy Ahmed M.^ORCID,Ragab Fatma A.F.,Ali Mamdouh M.,Abu-bakr Sherifa M.,Girgis Adel S.,El Diwani Hoda I.

Funder

National Research Centre

Science and Technology Development Fund’

National Institutes of Health National Center for Research Resources

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Cell proliferation and cancer;López-Sáez;Histol. Histopathol.,1998

2. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat. Med.,1995

3. Tumor angiogenesis: past, present and the near future;Kerbel;Carcinogenesis,2000

4. Mechanisms of angiogenesis;Karamysheva;Biochem. Mosc.,2008

5. Tyrosine kinases as targets in cancer therapy - successes and failures;Traxler;Expert Opin. Ther. Targets,2003

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFR^T790M: Molecular docking, ADMET, design, and syntheses;Archiv der Pharmazie;2024-08

2. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

3. New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity;Scientific Reports;2024-06-06

4. Benzimidazole-oxindole hybrids as multi-kinase inhibitors targeting melanoma;Bioorganic Chemistry;2024-05

5. In silico insights into design of novel VEGFR-2 inhibitors: SMILES-based QSAR modelling, and docking studies on substituted benzo-fused heteronuclear derivatives;SAR and QSAR in Environmental Research;2024-04-02